title: Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes.
abstract: BACKGROUND
  Diabetes increases the risk of breast and colorectal cancers and has an undetermined relationship to cervical cancer. Improved screenings for these cancers are effective in reducing cancer mortality.
  
  
  OBJECTIVE
  To examine the prevalence of receiving recommended screenings for these cancers and to assess the trends in the screening rates over time among US women with diagnosed diabetes in comparison with women without diabetes.
  
  
  METHODS
  Cross-sectional.
  
  
  METHODS
  A total of 63,650 to 182,168 adult women participated in the 1996-2006 (biennially) Behavioral Risk Factor Surveillance System.
  
  
  METHODS
  The prevalence of receiving cancer screenings was age-standardized to the 2000 US population. The adjusted prevalence and adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were estimated using logistic regression analyses. The linear trends in the screening rates were tested using orthogonal polynomial contrasts.
  
  
  RESULTS
  In 2006, women with diabetes had a lower adjusted prevalence (74% versus 79%, P < 0.05) and the AOR (0.73, 95% CI: 0.66-0.81) for receiving cervical cancer screenings, but had a higher adjusted prevalence (63% versus 60%, P < 0.05) and the AOR (1.14, 95% CI: 1.04-1.24) for receiving colorectal cancer screenings compared to those without. In both women with diabetes and those without, the screening rate for colorectal cancer increased linearly during 2002-2006, whereas the screening rates for breast and cervical cancers changed little during 1996-2006.
  
  
  CONCLUSIONS
  Women with diabetes were equally likely to be screened for breast cancer, less likely to be screened for cervical cancer, but more likely to be screened for colorectal cancer compared to those without. Overall, the screening rates in both groups remain below the recommended levels.
authors.affiliation: Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA. GZhao@cdc.gov
authors.forename: Guixiang
authors.initials: G
authors.lastname: Zhao
authors.forename: Earl S
authors.initials: ES
authors.lastname: Ford
authors.forename: Indu B
authors.initials: IB
authors.lastname: Ahluwalia
authors.forename: Chaoyang
authors.initials: C
authors.lastname: Li
authors.forename: Ali H
authors.initials: AH
authors.lastname: Mokdad
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003920:Diabetes Mellitus / Q000175:diagnosis* / Q000453:epidemiology*; D055088:Early Detection of Cancer; D005260:Female; D015438:Health Behavior; D006801:Humans; D008875:Middle Aged; D011159:Population Surveillance / Q000379:methods; D015995:Prevalence; D014481:United States / Q000453:epidemiology; D055815:Young Adult